Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations, namely, pharmaceutical preparations for the treatment of inflammation

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79249249

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 21405

44D Filed

44D Current

44E filed

44E Current

66A Filed

Yes

66A Current

Yes

Current Basis

No Basis

Legal History

Status Date	Action Taken
20^th Aug 2024	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03^rd Jan 2020	FINAL DECISION TRANSACTION PROCESSED BY IB
13^th Dec 2019	FINAL DISPOSITION NOTICE SENT TO IB
13^th Dec 2019	FINAL DISPOSITION PROCESSED
20^th Nov 2019	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20^th Aug 2019	REGISTERED-PRINCIPAL REGISTER
04^th Jun 2019	PUBLISHED FOR OPPOSITION
04^th Jun 2019	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15^th May 2019	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26^th Apr 2019	ASSIGNED TO LIE

MUSPAGDU

Classification Information

Class [005]Pharmaceutical Products